Johnson & Johnson (JNJ) develops, manufactures and markets health care products on a global basis. JNJ has 3 product segments: consumer health care products, pharmaceutical products and medical devices and diagnostic products.
Among the consumer products are those used for skin care, baby care, oral care, women’s health care, wound care, nutritional products etc.
The pharmaceutical products include anti-infective, contraceptive, gastrointestinal, dermatology, hematology, neurology, immunology, oncology etc.
The medical devices segment includes blood glucose monitoring, insulin delivery products, disposable contact lenses, aesthetics, surgical care, woman’s products and sports medicine products, etc.
J&J has a wide range of products which offers both stability due to diversity and growth potential since most of these products are constantly developing.
J&J’s stock has been moving sideways, fluctuating between $1120 and $1260 over the last 4 months since August, 2011. In addition, this company gives a good dividend. This stock would be good for a long term investment, especially if one sells when it goes down and buys when it goes up.
Some of the top executives and directors are Alex Gorsky, Sheri S. McCoy, Peter Fasolo Ph.D, William D. Perez, Leo F. Mullin, David Satcher, M.D., Ph.D., and Russell C. Deyo.
Disclaimer: The information in this article is not extensive enough for making investment decisions. All such decisions should be preceded by a thorough analysis of the stock.
Sorry, comments are closed for this post.